EMEA-001537-PIP01-13 - paediatric investigation plan

Caffeine

Ibuprofen

Key facts

• Active Substance:
  • Caffeine
  • Ibuprofen
• Therapeutic area:
  Pain
• Decision number:
  P/0024/2014
• PIP number:
  EMEA-001537-PIP01-13
• Pharmaceutical form(s):
  Film-coated tablet
• Condition(s) / indication(s):
  Treatment of pain
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  22/01/2014

Decision

P/0024/2014: EMA decision of 22 January 2014 on the granting of a product-specific waiver for caffeine / ibuprofen (EMEA-001537-PIP01-13)

AdoptedReference Number: EMA/12526/2014